Golimumab
2 results
Applied filters
The licence and supporting evidence for golimumab biosimilar
28 November 2025We highlight evidence for licensed golimumab biosimilar(s) and differences between the biosimilar(s) and the reference product (Simponi).
Preparing to use golimumab biosimilar
21 May 2025Golimumab biosimilars are expected soon. We offer general information and implementation advice.